eli lilly - Search News

News

Eli Lilly Vows to Make Weight-Loss Pill in U.S.

Eli Lilly’s stock soars as successful trial of weight-loss pill is a game changer

If approved, the pill is expected to be far easier to administer than current injectables — and far easier to manufacture.

The New York Times · 18h

What to Know About Eli Lilly’s Daily Pill for Weight Loss

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.

UPI on MSN · 14h

Experimental Eli Lilly weight loss drug proves promising for type 2 diabetics

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its latest clinical testing, the Indianapolis-based drugmaker announced Thursday.

UnitedHealth, Eli Lilly, Netflix

Forbes · 1d

Why It Makes Sense To Buy Eli Lilly Stock At $840

The trial met its primary objectives, showing the pill’s effectiveness in helping patients with Type 2 diabetes achieve improved blood sugar control and weight loss.

Bloomberg · 12h

Stock Movers: UnitedHealth, Eli Lilly, Netflix

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Reuters on MSN · 20h

Eli Lilly lifts S&P 500, UnitedHealth plummets

The S&P 500 rose on Thursday, lifted by Eli Lilly and Apple, as investors weighed progress in U.S. trade negotiations with Japan against concerns about the outlook for interest rates. Traders leaned toward optimism following U.

17m

Eli Lilly CEO Ricks Warns Against Unintentionally Raising Prices as Weight-Loss Pill Nears Market Launch

Eli Lilly is getting closer to bringing a weight loss pill to market, but CEO David Ricks notes certain factors need to be considered to prevent prices from ballooning.

7hon MSN

Where Will Eli Lilly Be in 5 Years?

What a difference five years can make. Just look at Eli Lilly (NYSE: LLY). In April 2020, the drugmaker stood in the shadows ...

Fierce Biotech1d

Lilly's oral GLP-1 drug delivers Ozempic-like efficacy in phase 3 diabetes trial

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. | Eli Lilly has met its goal of ...

Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch

U.S. pharma giant Eli Lilly And Co (NYSE:LLY) announced the launch of its popular weight loss drug Mounjaro (tirzepatide) in ...

23hon MSN

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results